Artificial heart to give new hope to heart failure patients
A revolutionary, implantable mechanical device to be tested at The Alfred is set to provide new hope to patients with debilitating heart failure.
Visitor information – Everything you need to know about visiting our sites.
Associate Professor James Hare and his colleagues in the Cardiac Amyloidosis service are involved in a number of new clinical trials to develop new treatments for patients.
These studies are international leading trials with ground-breaking developments in the field.
Please contact us if you would like to discuss any of these trials.
Contact – cardiacamyloid@alfred.org.au
A/Prof James Hare is a cardiologist in the Heart Failure & Transplant service at The Alfred in Melbourne.
A revolutionary, implantable mechanical device to be tested at The Alfred is set to provide new hope to patients with debilitating heart failure.
Heart patients of the future are set to benefit from a new partnership which will bring together the combined strengths of three leading institutions in cardiovascular research and patient care.
When 43-year-old Melbourne dad Mark Wohlers suffered a cardiac arrest last year, it was the swift emergency response and an Australian-first clinical trial that gave him a second chance at life.